Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a cross-sectional survey
- PMID: 34548362
- PMCID: PMC8457995
- DOI: 10.1136/bmjopen-2021-051836
Prevalence and risk factors for SARS-CoV-2 infection in children with and without symptoms seeking care in Managua, Nicaragua: results of a cross-sectional survey
Abstract
Objective: This study aimed to capture key epidemiological data on SARS-CoV-2 infection in Nicaraguan children (≤18 years) seeking medical care, between 6 October and 16 November 2020.
Design: In this cross-sectional study, 418 children were recruited: 319 with symptoms characteristic of COVID-19 and 99 with no symptoms of illness. Children were tested for SARS-CoV-2 RNA using loop-mediated isothermal amplification. A questionnaire was employed to identify symptoms, risk factors, comorbidities and COVID-19 prevention measures.
Setting: Research was carried out in four hospitals and two clinics in Managua, Nicaragua, where schools and businesses remained open throughout the COVID-19 pandemic.
Participants: Children were enrolled into a possible COVID-19 group if presenting with clinical symptoms. A comparison group included children lacking any COVID-19 symptoms attending routine check-ups or seeking care for issues unrelated to COVID-19.
Results: A high prevalence (43%) of SARS-CoV-2 infection was found, which was relatively equivalent in symptomatic and non-symptomatic children. Age distribution was similar between symptomatic and non-symptomatic children testing positive for SARS-CoV-2. Symptomatic children who tested positive for SARS-CoV-2 were 2.7 times more likely to have diarrhoea (26.7% in positive vs 12.0% in negative; OR=2.7 (95% CI 1.5 to 4.8), p=0.001) and were 2.0 times more likely to have myalgia (17.8% in positive vs 9.8% in negative; OR=2.0 (95% CI 1.0 to 3.8), p=0.04). Children with COVID-19 symptoms, who tested positive for SARS-CoV-2, were more likely to be under age 5 years and to have a pre-existing comorbid condition than children who tested positive but did not have symptoms.
Conclusions: This is the first paediatric study to provide laboratory-confirmed data on SARS-CoV-2 infection in Nicaragua, crucial for paediatric health services planning and a successful COVID-19 response. The high prevalence of the virus suggests widespread and sustained community transmission, underscoring the urgent need for robust data on the true extent of SARS-CoV-2 infection throughout Nicaragua.
Keywords: COVID-19; epidemiology; molecular diagnostics; paediatrics; public health.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- World Health Organization . WHO coronavirus disease (COVID-19) dashboard [online]. Geneva, 2020. https://covid19.who.int/
-
- Díaz López K. Vacunas contra el Covid-19 en Nicaragua: Cuántas tiene aseguradas el país para los próximos días [ Vaccines against Covid-19 in Nicaragua: how many has the country secured for the next few days]. La Prensa [online], 2021. Available: https://www.laprensa.com.ni/2021/02/28/nacionales/2790405-vacunas-contra...
-
- Citizen Observatory . Observatorio Ciudadano COVID-19 en Nicaragua. Informe Semanal 11/02/2021 al 17/02/2021 [Citizen Observatory COVID-19 weekly report in Nicaragua 02/11/2021 to 02/17/2021 [online]. Available: https://observatorioni.org/informes-notas-y-semanales/ [Accessed 25 Nov 2020].
-
- Romero KT. Fatality in the country soared in 2020 due to the pandemic. Confidencial 2021. https://confidencial.com.ni/nacion/mortalidad-en-nicaragua-aumento-en-20...
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous